Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 5 Neoplasms 3 Recurrence 1 Neuroectodermal Tumors 1 Medulloblastoma 1 Brain Neoplasms 1

Interventions

repotrectinib 1 pralsetinib 1 pamiparib 1 Vincristine 1 Temozolomide 1 Radiotherapy 1 Radiation 1 Maintenance Chemotherapy 1 Lomustine 1 Interleukin-12 1 Cisplatin 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neuroectodermal Tumors × Lomustine × Clear all

NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡